Clinical Trials in France / NCT07851051
Recruiting
Observational
Study of Individual Neurocognitive Changes Associated With the Training of the Working Memory.
NCT07851051 · tracked via the Priya Life Science France tracker
Condition(s) studied
Mental Health
Study summary
8 participants including 2 pilots. The 2 pilot participants will each execute an MRI acquisition session in order to adjust the experimental paradigm
Eligibility
Inclusion Criteria:
The inclusion criteria include
* age between 18 and 30 years,
* right-handedness (assessed using the Edinburgh Handedness Inventory),
* native French speaker, affiliation with the French national health insurance system
* provision of written informed consent prior to participation.
Exclusion Criteria:
Exclusion criteria include:
* contraindications to MRI,
* neurological or psychiatric disorders
* history of traumatic brain injury
* any geographical or psychological condition preventing full compliance with the study protocol.
Primary outcome measure(s)
- Working memory performance - Cogmed — 5 week.
Cognitive trajectories will be characterized using performance measures derived from the home-based training. - Working memory performance - CANTAB — 2 week
Cognitive trajectories will be characterized using performance measures derived from the Spatial Span (SSP) task from the CANTAB battery, administered under standardized conditions at GHU Paris Psychiatry and Neurosciences. - Multimodal MRI data — 2 week
Multimodal MRI data - including anatomical, resting-state, working memory (WM) task-based functional, and diffusion-weighted sequences - will be acquired repeatedly over a six-week period during WM training, as well as before and after the training phase.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CACHIA | Paris | France | Recruiting |
More Centre Hospitalier St Anne trials in France
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07851051 on ClinicalTrials.gov ↗ ← All trials in France